TrialCancer biology & therapy2019

Dynamic changes of different phenotypic and genetic circulating tumor cells as a biomarker for evaluating the prognosis of RCC.

Zhen-Long Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.